Rachel E. Sutton

5.8k citations

20 papers · 1.6k indexed · 3 hit papers · h-index 11

Impact in

Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Viral gastroenteritis research and epidemiology
Hematology top 5%
- Platelet Disorders and Treatments

Papers in ⓘ

Infectious Diseases 14
- Viral Infections and Vectors 8
- SARS-CoV-2 and COVID-19 Research 5
- Viral Infections and Outbreaks Research 5
- Viral gastroenteritis research and epidemiology 3
Internal Medicine 1

Co-authors: James E. Crowe (14 shared papers)Robert H. Carnahan (8 shared papers)Pavlo Gilchuk (6 shared papers)Seth J. Zost (5 shared papers)Rachel S. Nargi (9 shared papers)Naveenchandra Suryadevara (5 shared papers)Elad Binshtein (5 shared papers)Francesco Ferraro (3 shared papers)
Journals: Cell (6 papers)Cell Reports (2 papers)PLoS Pathogens (1 paper)EP Europace (1 paper)The Journal of Immunology (1 paper)
Partner nations: United States United Kingdom Germany

In The Last Decade

Rachel E. Sutton

18 papers receiving 1.5k citations

Hit Papers

align trajectories log scale

Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein 2021 · 215 citations

Peers

Countries citing papers authored by Rachel E. Sutton

Since Specialization

Citations

This map shows the geographic impact of Rachel E. Sutton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel E. Sutton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel E. Sutton more than expected).

Fields of papers citing papers by Rachel E. Sutton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel E. Sutton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel E. Sutton. The network helps show where Rachel E. Sutton may publish in the future.

Co-authors

The 25 scholars most cited alongside Rachel E. Sutton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rachel E. Sutton Line = papers co-authored together Rachel E. Sutton links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition Cell Host & Microbe ·Allison J. Greaney, Tyler N. Starr, Pavlo Gilchuk, Seth J. Zost, Elad Binshtein, Andrea N. Loes, Sarah K. Hilton, John Huddleston, Rachel Eguia, Katharine H. D. Crawford, Adam S. Dingens, Rachel S. Nargi, Rachel E. Sutton, Naveenchandra Suryadevara, Paul W. Rothlauf, Zhuoming Liu, Sean P. J. Whelan, Robert H. Carnahan, James E. Crowe, Jesse D. Bloom Hit paper breakdown →	2020	568
2	Endothelial von Willebrand factor regulates angiogenesis Blood ·Richard Starke, Francesco Ferraro, Koralia Paschalaki, Nicola H. Dryden, Thomas A. J. McKinnon, Rachel E. Sutton, Elspeth Payne, Dorian O. Haskard, Alun D. Hughes, Daniel F. Cutler, Michael Laffan, Anna M. Randi	2010	377
3	Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein Cell ·Naveenchandra Suryadevara, Swathi Shrihari, Pavlo Gilchuk, Laura A. VanBlargan, Elad Binshtein, Seth J. Zost, Rachel S. Nargi, Rachel E. Sutton, Emma S. Winkler, Elaine C. Chen, Mallorie E. Fouch, Edgar Davidson, Benjamin J. Doranz, Rita E. Chen, Pei‐Yong Shi, Robert H. Carnahan, Larissa B. Thackray, Michael Diamond, James E. Crowe Hit paper breakdown →	2021	215
4	Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection Cell ·Emma S. Winkler, Pavlo Gilchuk, Jinsheng Yu, Adam L. Bailey, Rita E. Chen, Zhenlu Chong, Seth J. Zost, Hyesun Jang, Ying Huang, James D. Allen, James Brett Case, Rachel E. Sutton, Robert H. Carnahan, Tamarand L. Darling, Adrianus C. M. Boon, Matthias Mack, Richard D. Head, Ted M. Ross, James E. Crowe, Michael Diamond Hit paper breakdown →	2021	183
5	Potent Henipavirus Neutralization by Antibodies Recognizing Diverse Sites on Hendra and Nipah Virus Receptor Binding Protein Cell ·Jinhui Dong, Robert W. Cross, Michael P. Doyle, Nurgun Kose, Jarrod J. Mousa, Edward J. Annand, Viktoriya Borisevich, Krystle N. Agans, Rachel E. Sutton, Rachel S. Nargi, Mahsa Majedi, Karla A. Fenton, Walter Reichard, Robin Bombardi, Thomas W. Geisbert, James E. Crowe	2020	41
6	Endothelial Von Willebrand factor regulates angiogenesis Vascular Pharmacology ·Richard Starke, Koralia Paschalaki, Francesco Ferraro, Nicola H. Dryden, Thomas A. J. McKinnon, Rachel E. Sutton, Elspeth Payne, Dorian O. Haskard, Alun D. Hughes, Daniel F. Cutler, Michael Laffan, Anna M. Randi	2012	31
7	Human Antibodies Protect against Aerosolized Eastern Equine Encephalitis Virus Infection Cell ·Lauren E. Williamson, Theron Gilliland, Pramod Kumar Yadav, Elad Binshtein, Robin Bombardi, Nurgun Kose, Rachel S. Nargi, Rachel E. Sutton, Clarissa L. Durie, Erica Armstrong, Robert H. Carnahan, Lauren Walker, Arthur S. Kim, Julie M. Fox, Michael Diamond, Melanie D. Ohi, William B. Klimstra, James E. Crowe	2020	27
8	Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blocking Nature Biotechnology ·Andrea R. Shiakolas, Kevin J. Kramer, Nicole V. Johnson, Steven C. Wall, Naveenchandra Suryadevara, Daniel Wrapp, Sivakumar Periasamy, Kelsey A. Pilewski, Nagarajan Raju, Rachel S. Nargi, Rachel E. Sutton, Lauren Walker, Ian Setliff, James E. Crowe, Alexander Bukreyev, Robert H. Carnahan, Jason S. McLellan, Ivelin S. Georgiev	2022	27
9	Potent neutralization of Rift Valley fever virus by human monoclonal antibodies through fusion inhibition Proceedings of the National Academy of Sciences ·Nathaniel S. Chapman, Haiyan Zhao, Nurgun Kose, Jonna B. Westover, Birte Kalveram, Robin Bombardi, Jessica Rodríguez, Rachel E. Sutton, Joseph R. Genualdi, A. Desirée LaBeaud, Francis Mutuku, Phillip R. Pittman, Alexander N. Freiberg, Brian B. Gowen, Daved H. Fremont, James E. Crowe	2021	23
10	Pan-ebolavirus protective therapy by two multifunctional human antibodies Cell ·Pavlo Gilchuk, Charles D. Murin, Robert W. Cross, Philipp A. Ilinykh, Kai Huang, Natalia A. Kuzmina, Viktoriya Borisevich, Krystle N. Agans, Joan B. Geisbert, Seth J. Zost, Rachel S. Nargi, Rachel E. Sutton, Naveenchandra Suryadevara, Robin Bombardi, Robert H. Carnahan, Alexander Bukreyev, Thomas W. Geisbert, Andrew B. Ward, James E. Crowe	2021	23
11	Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infection Cell Reports ·Taylor B. Engdahl, Natalia A. Kuzmina, Adam J. Ronk, Chad E. Mire, Matthew A. Hyde, Nurgun Kose, Matthew Josleyn, Rachel E. Sutton, Apoorva Mehta, Rachael M. Wolters, Nicole Lloyd, Francisca Valdivieso, Thomas G. Ksiazek, Jay W. Hooper, Alexander Bukreyev, James E. Crowe	2021	21
12	Epitope-focused immunogen design based on the ebolavirus glycoprotein HR2-MPER region PLoS Pathogens ·Clara T. Schoeder, Pavlo Gilchuk, Amandeep K. Sangha, Kaitlyn V. Ledwitch, Delphine C. Malherbe, Xuan Zhang, Elad Binshtein, Lauren E. Williamson, Cristina E. Martina, Jinhui Dong, Erica Armstrong, Rachel E. Sutton, Rachel S. Nargi, Jessica Rodríguez, Natalia A. Kuzmina, Brooke Fiala, Neil P. King, Alexander Bukreyev, James E. Crowe, Jens Meiler	2022	8
13	Isolation of a Potently Neutralizing and Protective Human Monoclonal Antibody Targeting Yellow Fever Virus mBio ·Michael P. Doyle, Joseph R. Genualdi, Adam L. Bailey, Nurgun Kose, Christopher Gainza, Jessica Rodríguez, Kristen M. Reeder, Christopher A. Nelson, Prashant N. Jethva, Rachel E. Sutton, Robin Bombardi, Michael L. Gross, Justin G. Julander, Daved H. Fremont, Michael Diamond, James E. Crowe	2022	8
14	Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein The Journal of Immunology ·Naveenchandra Suryadevara, Swathi Shrihari, Pavlo Gilchuk, Laura A. VanBlargan, Elad Binshtein, Seth J. Zost, Rachel S. Nargi, Rachel E. Sutton, Emma S. Winkler, Elaine C. Chen, Mallorie E. Fouch, Edgar Davidson, Benjamin J. Doranz, Robert H. Carnahan, Larissa B. Thackray, Michael Diamond, James E. Crowe	2021	5
15	Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infection Cell Reports ·Taylor B. Engdahl, Natalia A. Kuzmina, Adam J. Ronk, Chad E. Mire, Matthew A. Hyde, Nurgun Kose, Matthew Josleyn, Rachel E. Sutton, Apoorva Mehta, Rachael M. Wolters, Nicole Lloyd, Francisca Valdivieso, Thomas G. Ksiazek, Jay W. Hooper, Alexander Bukreyev, James E. Crowe	2021	3
16	Development of a Kinetic ELISA and Reactive B Cell Frequency Assay to Detect Respiratory Syncytial Virus Pre-Fusion F Protein-Specific Immune Responses in Infants Journal of the Pediatric Infectious Diseases Society ·Stephanie Rolsma, Sandra Yoder, Rachel S. Nargi, Eric Brady, Nurgun Kose, Natalia Jimenez‐Truque, Isaac Thomsen, Marissa Kontos, Robert H. Carnahan, Rachel E. Sutton, Erica Armstrong, Len Dally, James E. Crowe, Kathryn M. Edwards, C. Buddy Creech	2023	1
17	Essential Guide to Business in the Performing Arts Medical Entomology and Zoology ·Vivien Freakley, Rachel E. Sutton	1996	1
18	39 Blood-derived endothelial progenitor cells from Von Willebrand's disease patients demonstrate that Von Willebrand factor regulates angiogenesis Heart ·Richard Starke, Koralia Paschalaki, Francesco Ferraro, Nicola H. Dryden, Thomas A. J. McKinnon, Rachel E. Sutton, Elspeth Payne, Dorian O. Haskard, Alun D. Hughes, Daniel F. Cutler, Michael Laffan, Anna M. Randi	2011	1
19	High-resolution in situ structures of hantavirus glycoprotein tetramers Cell ·Luqiang Guo, Elizabeth McFadden, Megan M. Slough, E. Taylor Stone, Jacob Berrigan, Eva Mittler, Kiara Hatzakis, Troy Hinkley, Heather S. Kain, Zunlong Ke, Nikole L. Warner, Jesse H. Erasmus, Kartik Chandran, Rachel E. Sutton	2026	0
20	Association of incident fragility fractures in patients hospitalised due to unexplained syncope and orthostatic hypotension EP Europace ·Madeleine Johansson, Cecilia Rogmark, Rachel E. Sutton, Viktor Hamrefors, Artur Fedorowski	2021	0

About Rachel E. Sutton

Rachel E. Sutton is a scholar working on Infectious Diseases, Internal Medicine, Ecology, Evolution, Behavior and Systematics, Hematology and Urban Studies, having authored 20 papers that have together received 1.6k indexed citations. Recurring topics across this work include Viral Infections and Vectors (8 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Viral Infections and Outbreaks Research (5 papers), Vector-Borne Animal Diseases (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Viral gastroenteritis research and epidemiology (3 papers), Bacillus and Francisella bacterial research (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). The work is most often cited by research in Infectious Diseases (997 citations), Hematology (185 citations), Animal Science and Zoology (147 citations), Immunology (218 citations) and Modeling and Simulation (47 citations). Rachel E. Sutton has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include James E. Crowe, Robert H. Carnahan, Pavlo Gilchuk, Seth J. Zost, Rachel S. Nargi, Naveenchandra Suryadevara, Elad Binshtein, Francesco Ferraro, Nicola H. Dryden and Elspeth Payne. Their work appears in journals such as Cell, Cell Reports, PLoS Pathogens, EP Europace and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact